Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Åëdz¼º ¼ÒÀÎÀ» °¡Áø ¿ä»ê¼®°ú Ä®½·¼® ȯÀÚ¿¡¼­ »ýÈ­ÇÐÀû ¹× ÀÓ»óÀû ºñ±³ Biochemical and Clinical Comparison of Gouty Diathesis with Uric Acid and Calcium Stone

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 6È£ p.537 ~ 541
ÃÖ¸¸¼®, Á¤°æ¿ì, ¼º°æŹ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ¸¸¼® ( Choi Man-Sug ) 
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Á¤°æ¿ì (  ) 
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
¼º°æŹ (  ) 
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

¼­·Ð
¿ä¼®Àº ÈçÇÑ ºñ´¢±â°ú Áúȯ ÁßÀÇ Çϳª·Î ±¹¿Ü¿¡¼­´Â ±× ¿øÀΰú ¹ß»ý±âÀü¿¡ °üÇÑ ¿¬±¸°¡
È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖÀ¸³ª ±¹³»ÀÇ °æ¿ì ¹Ì¹ÌÇÑ ½ÇÁ¤ÀÌ´Ù. ¿ä¼®ÀÇ Ä¡·á´Â ¿Ü°úÀû Ä¡·á¿Í ³»°ú
Àû Ä¡·á·Î ±¸ºÐÇÒ ¼ö ÀÖÀ¸¸ç ¿Ü°úÀû Ä¡·á´Â ´ë°³ ü¿ÜÃæ°ÝÆļ⼮¼ú. °æÇÇÀû¿ä¼®Á¦°Å¼ú ¹×
°³º¹¼ö¼ú µîÀ¸·Î ¿ä¼®À» Á¦°ÅÇÔÀ» ÀǹÌÇÏ¸ç ³»°úÀû Ä¡·á´Â ¿ä¼®ÀÇ º´Å »ý¸®¸¦ ÆľÇÇÏ¿© Ä¡
·áÇÏ°í Àç¹ßÀ» ¾ïÁ¦ÇÏ´Â °ÍÀ» ÀǹÌÇÑ´Ù. Åëdz¼º ¼ÒÀÎÀ» °¡Áø ȯÀÚ±ºÀº °í¿ä»êÇ÷Áõ, Åëdz¼º°ü
Àý¿°°ú °á¼®À» °¡Áø ¿ø¹ß¼ºÅëdz°ú °í¿ä»êÇ÷ÁõÀ̳ª Åëdz¼º°üÀý¿°Àº ¾øÀ¸³ª °á¼®À» °¡Áø ÀáÀç
¼ºÅëdzÀ» °¡Áø ȯÀÚ±ºÀ» ¸»Çϸç, À̵éÀº ¿ä»ê¿°ÀÇ °ú »ý»ê, ¿ä»ê¿°Ã»¼ÒÀ² ÀúÇÏ, ÀáÀ缺Åëdz
À¸·Î ³ª´µ¾îÁú ¼ö ÀÖÀ¸¸ç Ư¡ÀûÀÎ ¼Ò°ßÀ¸·Î Áö¼ÓÀûÀÎ »ê¼º´¢¿Í °á¼®Çü¼ºÀ» ÇÑ´Ù. À̵éÀÌ
Çü¼ºÇÏ´Â °á¼®Àº ÁÖ·Î ¿ä»ê¼® ¶Ç´Â Ä®½·¼®ÀÌ´Ù. ¿ä»ê¼®Àº Àüü ¿ä¼®ÀÇ 5-10%¸¦ Â÷ÁöÇÏ°í
µå¹°Áö ¾Ê°Ô ¾çÃø½ÅÀåÀ» ħ¹üÇϸç Àç¹ß·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç ESWLÀ̳ª °üÇ÷Àû
¼ö¼úµîÀ¸·Î Ä¡·á ÈÄ ºÎ°¡Àû ¹× ¿¹¹æÀûÀ¸·Î ¾ËÄ®¸®È­ ¿ä¹ýÀ» ½ÃÇàÇÏ°í ÀÖÀ¸³ª, Àüü ¿ä¼®ÀÇ
´ëºÎºÐÀ» Â÷ÁöÇÏ´Â Ä®½·¼®Àº ¿øÀÎÀÌ ¹àÇôÁø ÀϺθ¦ Á¦¿ÜÇÏ°í´Â ºÎ°¡Àû ¹× ¿¹¹æÀû ¿ä¹ýÀ» ÇÏ
Áö ¸øÇÏ°í ´ëºÎºÐ ´ëÁßÀûÀÎ Ä¡·á¸¸ÇÏ°í ÀÖ´Ù. ÀÌ¿¡ ÀúÀÚµéÀº Åëdz¼º ¼ÒÀÎÀ» °¡Áø ¿ä»ê¼® ¶Ç
´Â Ä®½·¼® ȯÀÚ¿¡¼­ Á¤»ó ´ëÁ¶±º°ú »ýÈ­ÇÐÀû ¹× ÀÓ»óÀû Ư¼ºÀ» ¼­·Î ºñ±³ ºÐ¼®ÇÏ¿© °¢°¢ÀÇ
Ư¼ºÀ» ¾Ë¾Æº» ÈÄ ÇâÈÄ Åëdz¼º ¼ÒÀÎÀ» °¡Áø ¿ä¼®È¯ÀÚ Ä¡·á¿¡ ÁöħÀ» ¸¶·ÃÇÏ°íÀÚ ÇÑ´Ù.
#ÃÊ·Ï#
Purpose : We compared the biochemical and clinical presentation of gouty diathesis in
patients with uric acid and calcium nephrolithiasis
Materials and Methods : We retrospectively reviewed biochemical and clinical data
from 69 gouty diathesis patients(48 with uric acid stones and 21 with calcium stones)
and 57 normal subjects were performed at our institution.
Results : Demographic similarity between two groups was a male predominance.
Gouty diathesis patients in both groups showed abnormally low urinary pH(<5.5) and
propensity for hyperuricemia and hypertriglyceridemia. Gouty arthritis and hyperuricemia
was found in 31% and 44% of those with uric acid stones whereas 9.5% and 23.8% in
those with calcium stone respectively. In control group, 1 case presented with
hyperuricemia and urinary pH at 6.3. Both urinary pH and citrate increased after
potassium citrate treatment in both groups.
Conclusions : The two groups of gouty diathesis with either uric acid stone or
calcium stones have similar biochemical and clinical features that are characteristic of
primary gout. Calcium stone formation in patients with hyperuricemia or persistent acidic
urine may represent a latent form of gout. Patients with calcium stones and biochemical
feature of gouty diathesis may manifest primary gouty. Both groups are responsive to
potassium citrate treatment. (Korean J Urol 1998; 39: 537¡­41)

Å°¿öµå

Gouty diathesis; Uric acid stone; Calcium stone; Potassium citrate;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS